Torrent Pharmaceuticals Limited
TORNTPHARM
Pozycja w akcjach
#1201
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Cena akcji
$50.31
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$19.14B
Zmiana (1 dzień)
-0.14%
Zmiana (1 rok)
23.83%
Kraj
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategoria
Healthcare
Wskaźnik P/B dla Torrent Pharmaceuticals Limited (TORNTPHARM)
Wskaźnik P/B na dzień October 2026 TTM: 8.89
Według najnowszych raportów finansowych i ceny akcji Torrent Pharmaceuticals Limited, obecny wskaźnik P/B (TTM) wynosi 8.89. Na koniec 2024 wynosił 13.21.
Historia wskaźnika P/B dla Torrent Pharmaceuticals Limited od 2005 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 8.89 | -37.38% |
| 2025 | 14.19 | 7.48% |
| 2024 | 13.21 | 57.34% |
| 2023 | 8.39 | 5.76% |
| 2022 | 7.94 | 7.57% |
| 2021 | 7.38 | 6.65% |
| 2020 | 6.92 | 1.65% |
| 2019 | 6.81 | 46.79% |
| 2018 | 4.64 | -23.24% |
| 2017 | 6.04 | -9.75% |
| 2016 | 6.69 | -14.99% |
| 2015 | 7.87 | 68.81% |
| 2014 | 4.66 | 14.99% |
| 2013 | 4.06 | -9.26% |
| 2012 | 4.47 | -6.96% |
| 2011 | 4.80 | -13.51% |
| 2010 | 5.55 | 218.83% |
| 2009 | 1.74 | -25.49% |
| 2008 | 2.34 | -42.11% |
| 2007 | 4.04 | -23.55% |
| 2006 | 5.28 | 77.99% |
| 2005 | 2.97 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -43.26% |
IN
|
